January 26, 2023 4:49 pm
Published by Fluidda
Nanopharm and FLUIDDA collaborate to enable alternative bioequivalence pathways for orally inhaled drug products To support generic drug companies in obtaining a market license for their orally inhaled drug products... View Article
November 10, 2022 2:49 pm
Published by Fluidda
During the last ERS conference in Barcelona, Eline Lauwers, who recently obtained het PhD degree based on research partially conducted at Fluidda, presented a poster on her latest findings. She... View Article
October 4, 2022 4:08 pm
Published by Fluidda
The role of vascular density in pulmonary rehabilitation During the last ERS conference in Barcelona, Kris Ides, who works at the Antwerp University and in the MedImprove lung rehabilitation clinic... View Article
August 25, 2022 1:27 pm
Published by Fluidda
At the upcoming European Respiratory Society (ERS) 2022 conference, Fluidda is present with a booth and will be presenting 3 posters. From September 4th – 6th, we will exhibit at the annual conference... View Article
September 15, 2020 2:58 pm
Published by Fluidda
Lung Deposition of Two Bronchodilators in Subjects with COPD When Administered via Standard Jet Nebulizer or HandiHaler® Using FRI. During the ERS Congress 2020, a poster was presented comparing lung deposition of... View Article
September 11, 2020 11:00 am
Published by Fluidda
Functional Respiratory Imaging (FRI) shows significant regional ventilation defects in COPD patients as compared to healthy patients Ventilation defects in COPD are associated with reduced exercise tolerance and worse quality... View Article
September 9, 2020 11:32 am
Published by Fluidda
Ventilation-perfusion measures based on FRI correlates with exercise tolerance in COPD COPD affects the lungs in many ways. A common problem is reduced ventilation-perfusion (V/Q) values caused by airway disease... View Article
May 12, 2020 2:09 pm
Published by Fluidda
Fluidda studied the effectiveness of a new mobile HFCWO device for airway clearance in CF patients. High-frequency chest wall oscillation (HFCWO) is a commonly used airway clearance technique for cystic... View Article
January 27, 2020 12:13 pm
Published by Fluidda
High Frequency Chest Wall Oscillation (HFCWO) is a commonly used airway clearance technique for Cystic Fibrosis (CF) patients. At ERS 2019 in Madrid, a poster was presented on this topic.... View Article
January 8, 2020 11:00 am
Published by Fluidda
At the ERS 2019 conference in Madrid, our Director of Research and Development of Fluidda, gave his opinion on how Artificial Intelligence can help to improve the prediction of respiratory... View Article